Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 1/2005

Content (15 Articles)

Original Article

Inhibition by doxycycline of angiogenesis in the chicken chorioallantoic membrane (CAM)

Mary Richardson, David Wong, Samantha Lacroix, Jolanta Stanisz, Gurmit Singh

Original Article

Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study

Do Hyoung Lim, Young Suk Park, Byeong-Bae Park, Sang Hoon Ji, Jeeyun Lee, Keon Woo Park, Jung Hoon Kang, Se-Hoon Lee, Joon Oh Park, Kihyun Kim, Won Seog Kim, Chul Won Jung, Young-Hyuck Im, Won Ki Kang, Keunchil Park

Original Article

A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms

Richard L. Alexander, Bryan T. Greene, Suzy V. Torti, Gregory L. Kucera

Original Article

Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer

Jun Murakami, Jun-ichi Asaumi, Noriko Kawai, Hidetsugu Tsujigiwa, Yoshinobu Yanagi, Hitoshi Nagatsuka, Tetsuyoshi Inoue, Susumu Kokeguchi, Shoji Kawasaki, Masahiro Kuroda, Noriaki Tanaka, Nagahide Matsubara, Kanji Kishi

Original Article

A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109

Peter J. Van Veldhuizen, James R. Faulkner, Primo N. Lara Jr, Paul H. Gumerlock, J. Wendall. Goodwin, Shaker R. Dakhil, Howard M. Gross, Robert C. Flanigan, E. David. Crawford

Original Article

Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib

Bridget N. Fahy, Michael G. Schlieman, Melinda M. Mortenson, Subbulakshmi Virudachalam, Richard J. Bold

Original Article

Hyperthermic isolated regional perfusion with CDDP for bone and soft-tissue sarcoma of the lower limb: pharmacokinetics, thermal dose, toxicity, and feasibility

Satoshi Abe, Toru Tokizaki, Yuji Miki, Akio Tateishi, Kazuhiko Ogawa, Hirotaka Nakano, Takashi Matsushita

Original Article

American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats

Sangeeta Mehendale, Han Aung, Anbao Wang, Jun-Jie Yin, Chong-Zhi Wang, Jing-Tian Xie, Chun-Su Yuan

Original Article

Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule

Agustin A. Garcia, Mahesh Pujari, Susan Jeffers, Syma Iqbal, Heinz-Josef Lenz, Paul Beringer, Stan Louie

Original Article

Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity

Yanlin Wang, Amy Hacker, Tracy Murray-Stewart, Benjamin Frydman, Aldonia Valasinas, Alison V. Fraser, Patrick M. Woster, Robert A. Casero Jr

Original Article

Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy

Toshiaki Sendo, Naoko Sakai, Yoshinori Itoh, Hiroaki Ikesue, Hiroaki Kobayashi, Toshio Hirakawa, Hitoo Nakano, Ryozo Oishi

Original Article

Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck

Jeffrey R. Jaglowski, Ian S. Zagon, Brendan C. Stack Jr., Michael F. Verderame, Alphonse E. Leure-duPree, Jeffrey D. Manning, Patricia J. McLaughlin

Original Article

Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer

Selvanathan Saravana Perumal, Palanivelu Shanthi, Panchanadham Sachdanandam

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine